James Wooldridge

2017

In 2017, James Wooldridge earned a total compensation of $932.6K as Chief Medical Officer at Aeglea BioTherapeutics.

Compensation breakdown

Bonus$59,000
Salary$162,917
Stock Awards$393,409
Other$317,262
Total$932,588

Wooldridge received $393.4K in stock awards, accounting for 42% of the total pay in 2017.

Wooldridge also received $59K in bonus, $162.9K in salary and $317.3K in other compensation.

Rankings

In 2017, James Wooldridge's compensation ranked 9,293rd out of 14,666 executives tracked by ExecPay. In other words, Wooldridge earned more than 36.6% of executives.

ClassificationRankingPercentile
All
9,293
out of 14,666
37th
Division
Manufacturing
3,571
out of 5,768
38th
Major group
Chemicals And Allied Products
1,225
out of 2,074
41st
Industry group
Drugs
984
out of 1,730
43rd
Industry
Pharmaceutical Preparations
773
out of 1,329
42nd
Source: SEC filing on April 16, 2018.

Wooldridge's colleagues

We found three more compensation records of executives who worked with James Wooldridge at Aeglea BioTherapeutics in 2017.

2017

David Lowe

Aeglea BioTherapeutics

Chief Executive Officer

2017

Charles York

Aeglea BioTherapeutics

Chief Financial Officer

2017

Anthony Quinn

Aeglea BioTherapeutics

Chief Executive Officer

News

You may also like